Building on the Biomarker Breakthrough: What We’re Working on Now

Just over a year ago, there was a major breakthrough in Parkinson’s disease (PD) research – a tool that could detect abnormal alpha-synuclein protein in the spinal fluid of people living with PD even before onset of symptoms. This discovery is already impacting the ways scientists conduct and think about Parkinson’s research. Tune into this episode of our award-winning “Parkinson’s Science POV” series to learn  how researchers are using the test to better understand disease biology and what the future holds.    

Like our podcasts? Please consider leaving a rating or review and sharing the series with your community. https://apple.co/3p02Jw0 

The Foundation’s landmark study, the Parkinson’s Progression Markers Initiative, also known as PPMI, is recruiting volunteers. Join the study that’s changing everything at michaeljfox.org/podcast-ppmi. 

Mentioned in this episode:

This Giving Tuesday, December 3, you can help us sustain and grow the momentum in Parkinson’s research. All donations will be matched up to $4 million, which means your impact will be doubled. Visit michaeljfox.org/match2024 to help us accelerate research and be part of the cure.